As of 2025-07-06, the Relative Valuation of Vertex Pharmaceuticals Inc (VRTX) is (23.07) USD. This relative valuation is based on P/E multiples. With the latest stock price at 459.62 USD, the upside of Vertex Pharmaceuticals Inc based on Relative Valuation is -105.0%.
The range of the Relative Valuation is (55.68) - 27.10 USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 14.5x - 22.0x | 18.2x |
| Forward P/E multiples | 16.2x - 25.2x | 22.0x |
| Fair Price | (55.68) - 27.10 | (23.07) |
| Upside | -112.1% - -94.1% | -105.0% |
| Date | P/E |
| 2025-07-03 | -119.36 |
| 2025-07-02 | -118.68 |
| 2025-07-01 | -117.42 |
| 2025-06-30 | -115.61 |
| 2025-06-27 | -114.60 |
| 2025-06-26 | -115.14 |
| 2025-06-25 | -115.77 |
| 2025-06-24 | -116.93 |
| 2025-06-23 | -115.18 |
| 2025-06-20 | -114.49 |
| 2025-06-18 | -116.44 |
| 2025-06-17 | -114.78 |
| 2025-06-16 | -117.09 |
| 2025-06-13 | -118.27 |
| 2025-06-12 | -119.47 |
| 2025-06-11 | -117.49 |
| 2025-06-10 | -117.25 |
| 2025-06-09 | -115.86 |
| 2025-06-06 | -116.99 |
| 2025-06-05 | -115.25 |
| 2025-06-04 | -115.78 |
| 2025-06-03 | -115.94 |
| 2025-06-02 | -115.67 |
| 2025-05-30 | -114.79 |
| 2025-05-29 | -116.10 |
| 2025-05-28 | -115.58 |
| 2025-05-27 | -115.82 |
| 2025-05-23 | -113.22 |
| 2025-05-22 | -112.71 |
| 2025-05-21 | -113.04 |
| 2025-05-20 | -116.12 |
| 2025-05-19 | -114.43 |
| 2025-05-16 | -113.91 |
| 2025-05-15 | -112.80 |
| 2025-05-14 | -109.37 |
| 2025-05-13 | -112.18 |
| 2025-05-12 | -114.10 |
| 2025-05-09 | -110.36 |
| 2025-05-08 | -111.56 |
| 2025-05-07 | -112.92 |
| 2025-05-06 | -116.86 |
| 2025-05-05 | -129.89 |
| 2025-05-02 | -130.14 |
| 2025-05-01 | -129.55 |
| 2025-04-30 | -132.31 |
| 2025-04-29 | -130.75 |
| 2025-04-28 | -128.93 |
| 2025-04-25 | -128.24 |
| 2025-04-24 | -127.89 |
| 2025-04-23 | -127.87 |